Siolta Therapeutics
Phase 2Siolta Therapeutics is a clinical-stage company developing live biotherapeutics that target the core drivers of disease. Learn more.
Founded
2015
Focus
Microbiome
About
Siolta Therapeutics is a clinical-stage company developing live biotherapeutics that target the core drivers of disease. Learn more.
Funding History
2Total raised: $105M
Series B$75MKhosla VenturesMar 15, 2021
Series A$30MKhosla VenturesOct 15, 2018
Company Info
TypePrivate
Founded2015
LocationSan Francisco, United States
StagePhase 2
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile